Meta-Analysis Data Pooling May Mask Favorable Results - FDA's Temple
This article was originally published in The Tan Sheet
Executive Summary
Pooling data for a meta-analysis of clinical trials could mask favorable results in specific settings, FDA Center for Drug Evaluation & Research Associate Director for Medical Policy Robert Temple, MD, says in a commentary piece published in the March 3 Journal of the American Medical Association.